90 likes | 128 Views
Precision medicine market report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities. Market estimations are based on comprehensive analysis of the key developments in the industry.<br>
E N D
Opportunity Analysis and Industry Forecast, 2016-2023 The Future of Precision Medicine Runs Through the Pharma Industry Global Opportunity Analysis and Industry Forecast, 2017-2023
Precision Medicine Market “Versatile nature of precision medicine sets it apart from competition by helping doctor to personalize the therapeutic approach. ”
Precision Medicine Market Overview Precision Medicine Market by Technology, Application and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global precision medicine market accounted for $3,516 million in 2016, and is estimated to reach at $7,746 million by 2023, registering a CAGR of 11.9% from 2017 to 2023. North America was the highest contributor in the precision medicine market in 2016; however, Asia-Pacific is anticipated to witness a highest growth rate throughout the forecast period. Access Full Summary at: https://www.alliedmarketresearch.com/precision-medicine-market Precision medicine is novel approach toward disease treatment in healthcare, medications are customized based on patients personalized healthcare needs such as, influence of genes & surrounding environment on patients health and result of various tests carried out on various levels.
Precision Medicine Market Precision medicine commonly includes use of system biology and panomics to determine the reason for an individual patient's illness at the molecular level. Followed by the use of concentrated medications to address individual patient's illness. Precision medicine offers many advantages such as efficient treatment customized to patients needs and category of disease. Moreover, precision medicine can reduce cost of treatment and help decrease repeated administration of medications. The precision medicine market is segmented based on technology, sequencing technology, product, application and geography. Based on technology, it is divided into genomics, transcriptomics and epigenomics. Based on sequencing technology, the market is bifurcated into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, chain termination sequencing and nanopore sequencing.
Precision Medicine Market, Snapshot The report provides extensive competitive analysis and profiles of key market players, such as, Roche Holding AG, Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Quest Diagnostics, Laboratory Corporation of America Holdings, Novartis AG, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly & Company. The other players in the value chain include Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, and Pfizer Inc.
Key Benefits of the Precision Medicine Market • This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities. • Market estimations are based on comprehensive analysis of the key developments in the industry. • In-depth analysis based on geography assists to understand the regional market and the strategic business planning. • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
Precision Medicine Market North America Europe Asia-Pacific LAMEA
Precision Medicine Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/2311 Follow Us On